StockData

Pro Dex vs SS Innovations International

PDEX and SSII side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How PDEX and SSII compare

SS Innovations International is the larger company, worth 1.6 times as much as Pro Dex ($333M against $210M).

SS Innovations International grew revenue faster over the last twelve months (89.7% versus 13.3% for Pro Dex).

Pro Dex keeps more of each dollar of sales as profit, with a net margin of 15.1% compared with −23.7% at SS Innovations International.

Pro Dex scores higher on the StockData Score (18 against 8 for SS Innovations International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricPDEXSSII
Size and price
Market cap$210M$333M
Share price$65.66$1.66
Change, 1 year102%−75.5%
Change, 5 years221%–
Beta (5Y)0.25–
Employees18181
StockData Score
Total score18 (better)8
Valuation score22
Growth score4 (better)2
Performance score6 (better)2
Health score6 (better)2
Dividend score00
Valuation
P/E18.1×–
P/S2.6× (better)6.3×
P/B4.3× (better)6.2×
EV/EBITDA14.1×–
P/FCF19.7×–
PEG0.64–
FCF yield5.1%–
Fair value$70.21$3.56
Margin of safety6.5%53.4% (better)
Growth
Revenue growth (TTM)13.3%89.7% (better)
Revenue growth, 5Y average15.3%–
Net income growth (TTM)7.5%–
EPS growth (TTM)8.4%–
EPS growth, 5Y average21.3%–
Profitability
Gross margin32.5%47.6% (better)
Operating margin16.8% (better)−16.2%
Net margin15.1% (better)−23.7%
FCF margin13.4%–
Return on equity26.5% (better)−26.1%
Return on invested capital24.1% (better)−20.9%
Financial health
Debt / equity0.25–
Net debt / EBITDA−0.05–
Interest coverage15.4× (better)−7.4×
Current ratio4.19 (better)2.24
Altman Z-score7.79 (better)4.43
Piotroski F-score6 (better)5
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions22.9%0.82%
Held by insiders45.7%76.7%
Insider net buying, 12 months−$2.0M$5.1M (better)
Superinvestors holding1–
Short interest, % of float15.6%0.14%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.